Reportable Segments — Net losses on financial instruments
Elevance Health Reportable Segments — Net losses on financial instruments decreased by 36.8% to -$78.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 83.2%, from -$464.00M to -$78.00M. Over 3 years (FY 2022 to FY 2025), Reportable Segments — Net losses on financial instruments shows a downward trend with a 5.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in losses signals poor investment performance or adverse market conditions, whereas a decrease suggests stable or improving asset values.
Detailed definition
This metric captures the realized and unrealized losses incurred on financial assets held by a business segment, such as...
Peer comparison
Standard risk metric for insurance companies; peers often report this as part of comprehensive income or investment results.
elv_segment_reportable_segments_net_losses_on_financial_instrumentsHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$137.50M | -$137.50M | -$137.50M | -$137.50M | -$173.50M | -$173.50M | -$173.50M | -$173.50M | -$161.00M | -$85.00M | -$125.00M | -$74.00M | -$464.00M | -$131.00M | -$1.00M | -$57.00M | -$78.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -26.2% | +0.0% | +0.0% | +0.0% | +7.2% | +47.2% | -47.1% | +40.8% | -527.0% | +71.8% | +99.2% | <-999% | -36.8% |
| YoY Change | — | — | — | — | -26.2% | -26.2% | -26.2% | -26.2% | +7.2% | +51.0% | +28.0% | +57.3% | -188.2% | -54.1% | +99.2% | +23.0% | +83.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's reportable segments — net losses on financial instruments?
- Elevance Health (ELV) reported reportable segments — net losses on financial instruments of -$78.00M in Q1 2026.
- How has Elevance Health's reportable segments — net losses on financial instruments changed year-over-year?
- Elevance Health's reportable segments — net losses on financial instruments increased by 83.2% year-over-year, from -$464.00M to -$78.00M.
- What is the long-term trend for Elevance Health's reportable segments — net losses on financial instruments?
- Over 3 years (2022 to 2025), Elevance Health's reportable segments — net losses on financial instruments has grown at a 5.9% compound annual growth rate (CAGR), from -$550.00M to -$653.00M.
- What does reportable segments — net losses on financial instruments mean?
- The financial losses recorded by a business segment from its investment holdings.